These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 24465048)

  • 41. Timing of Insulin Injections, Adherence, and Glycemic Control in a Multinational Sample of People with Type 2 Diabetes: A Cross-Sectional Analysis.
    Schaper NC; Nikolajsen A; Sandberg A; Buchs S; Bøgelund M
    Diabetes Ther; 2017 Dec; 8(6):1319-1329. PubMed ID: 29063510
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The relationship between patients' perception of type 2 diabetes and medication adherence: a cross-sectional study in Japan.
    Hashimoto K; Urata K; Yoshida A; Horiuchi R; Yamaaki N; Yagi K; Arai K
    J Pharm Health Care Sci; 2019; 5():2. PubMed ID: 30693091
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Real-world Evaluation of glycemic control and hypoglycemic Events among type 2 Diabetes mellitus study (REEDS): a multicentre, cross-sectional study in Thailand.
    Satirapoj B; Pratipanawatr T; Ongphiphadhanakul B; Suwanwalaikorn S; Benjasuratwong Y; Nitiyanant W
    BMJ Open; 2020 Feb; 10(2):e031612. PubMed ID: 32051301
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adherence to antihypertensive medications among family practice patients with diabetes mellitus and hypertension.
    Natarajan N; Putnam W; Van Aarsen K; Beverley Lawson K; Burge F
    Can Fam Physician; 2013 Feb; 59(2):e93-e100. PubMed ID: 23418264
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Changes in weight loss-related quality of life among type 2 diabetes mellitus patients treated with dapagliflozin.
    Grandy S; Hashemi M; Langkilde AM; Parikh S; Sjöström CD
    Diabetes Obes Metab; 2014 Jul; 16(7):645-50. PubMed ID: 24443876
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prescription of lipid-lowering medications for patients with type 2 diabetes mellitus and risk-associated LDL cholesterol: a nationwide study of guideline adherence from the Swedish National Diabetes Register.
    Karlsson SA; Franzén S; Svensson AM; Miftaraj M; Eliasson B; Andersson Sundell K
    BMC Health Serv Res; 2018 Nov; 18(1):900. PubMed ID: 30486824
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of medication adherence among Lebanese diabetic patients.
    Mroueh L; Ayoub D; El-Hajj M; Awada S; Rachidi S; Zein S; Al-Hajje A
    Pharm Pract (Granada); 2018; 16(4):1291. PubMed ID: 30637030
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Real-world weight change among patients treated with glucagon-like peptide-1 receptor agonist, dipeptidyl peptidase-4 inhibitor and sulfonylureas for type 2 diabetes and the influence of medication adherence.
    Carls GS; Tan R; Zhu JY; Tuttle E; Yee J; Edelman SV; Polonsky WH
    Obes Sci Pract; 2017 Sep; 3(3):342-351. PubMed ID: 29071110
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Medication adherence in type 2 diabetes: the ENTRED study 2007, a French Population-Based Study.
    Tiv M; Viel JF; Mauny F; Eschwège E; Weill A; Fournier C; Fagot-Campagna A; Penfornis A
    PLoS One; 2012; 7(3):e32412. PubMed ID: 22403654
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Self-reported prevalence and awareness of metabolic syndrome: findings from SHIELD.
    Lewis SJ; Rodbard HW; Fox KM; Grandy S;
    Int J Clin Pract; 2008 Aug; 62(8):1168-76. PubMed ID: 18452535
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
    Krentz AJ; Bailey CJ
    Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of antidiabetic medication adherence in the Lebanese population: development of the Lebanese Diabetes Medication Adherence Scale.
    Ayoub D; Mroueh L; El-Hajj M; Awada S; Rachidi S; Zein S; Al-Hajje A
    Int J Pharm Pract; 2019 Oct; 27(5):468-476. PubMed ID: 31264750
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Self-reported hypoglycemia and impact on quality of life and depression among adults with type 2 diabetes mellitus.
    Green AJ; Fox KM; Grandy S;
    Diabetes Res Clin Pract; 2012 Jun; 96(3):313-8. PubMed ID: 22296853
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Improving medication adherence among patients with type 2 diabetes.
    Meece J
    J Pharm Pract; 2014 Apr; 27(2):187-94. PubMed ID: 24375997
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment Strategy for Type 2 Diabetes with Obesity: Focus on Glucagon-like Peptide-1 Receptor Agonists.
    Ji Q
    Clin Ther; 2017 Jun; 39(6):1244-1264. PubMed ID: 28526416
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Influence of patients' disease knowledge and beliefs about medicines on medication adherence: findings from a cross-sectional survey among patients with type 2 diabetes mellitus in Palestine.
    Sweileh WM; Zyoud SH; Abu Nab'a RJ; Deleq MI; Enaia MI; Nassar SM; Al-Jabi SW
    BMC Public Health; 2014 Jan; 14():94. PubMed ID: 24479638
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of gender and depression on oral medication adherence in persons with type 2 diabetes mellitus.
    Nau DP; Aikens JE; Pacholski AM
    Gend Med; 2007 Sep; 4(3):205-13. PubMed ID: 18022588
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Illness Perception and Medication Adherence among Adult Patients with Type 2 Diabetes Mellitus: A Scoping Review.
    Alharbi S; Alhofaian A; Alaamri MM
    Clin Pract; 2023 Jan; 13(1):71-83. PubMed ID: 36648847
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Barriers to Prevention and Treatment of Type 2 Diabetes Mellitus Among Outpatients in Belarus.
    Sachkouskaya A; Sharshakova T; Kovalevsky D; Rusalenko M; Savasteeva I; Goto A; Yokokawa H; Kumagai A; Takahashi J
    Front Clin Diabetes Healthc; 2021; 2():797857. PubMed ID: 36994323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.